Calcium/calmodulin-dependent kinase II regulates notch-1 signaling in prostate cancer cells

Olga A Mamaeva1, Junghyun Kim, Gong Feng

  • 1Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama 35249-7331, USA.

Insights

Calcium/calmodulin-dependent kinase II (CaMKII) interacts with Notch-1 signaling in prostate cancer bone metastasis. Inhibiting CaMKII or gamma-secretase impacts cancer cell proliferation and invasion, suggesting new therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Notch signaling is implicated in prostate cancer bone metastases.
  • Calcium/calmodulin-dependent kinase II (CaMKII) is crucial for osteoblastogenesis.
  • Prostate cancer cell lines exhibit differential Notch-1 receptor and CaMKII isoform expression based on metastatic origin.

Purpose of the Study:

  • To investigate the relationship between CaMKII and Notch-1 signaling in prostate cancer bone metastasis.
  • To explore the functional consequences of inhibiting CaMKII and Notch signaling on cancer cell behavior.

Main Methods:

  • Comparative analysis of Notch-1 and CaMKII expression in prostate cancer cell lines.
  • Pharmacological inhibition of CaMKII (KN93) and gamma-secretase (L-685,458).
  • siRNA-mediated knockdown and overexpression of CaMKII isoforms.
  • Assessment of downstream Notch signaling markers (Hes-1, c-Myc), cell proliferation, and invasion.

Main Results:

  • Prostate cancer cells from bone metastases (C4-2B, PC3) express Notch-1 and all CaMKII isoforms, unlike non-metastatic cells (LNcaP, DU145).
  • Inhibition of CaMKII or gamma-secretase reduced cleaved Notch-1, Hes-1 expression, and c-Myc levels.
  • Both inhibitors suppressed proliferation and Matrigel invasion of C4-2B cells.
  • CaMKII-alpha overexpression enhanced Hes-1 expression, indicating CaMKII's role in Notch-1 signaling.

Conclusions:

  • A novel crosstalk exists between CaMKII and Notch-1 pathways in prostate cancer bone metastasis.
  • CaMKII activity is essential for Notch-1 signaling, proliferation, and invasion in metastatic prostate cancer cells.
  • This interaction presents potential therapeutic targets for treating prostate cancer bone metastases.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...